Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GeoVax reports positive data from full-dose phase I HIV/AIDS vaccine human trial

Nov. 8, 2007

European AIDS Conference: Studies of atazanavir/ritonavir

Nov. 8, 2007

Studies describe raltegravir resistance, pharmacokinetics, efficacy

Nov. 7, 2007

TMC-278 effects on lipids, coadministration with atorvastatin reported

Nov. 7, 2007

Panacos announces preliminary results from the 300 mg cohort in a phase IIb trial of bevirimat

Oct. 30, 2007

GenVec receives additional funding to develop novel adenovector-based HIV vaccines

Oct. 25, 2007

European CHMP issues positive opinion for Atripla in HIV/AIDS; Health Canada gives its approval

Oct. 19, 2007

Viracept license in Europe reinstated by EC

Oct. 19, 2007

Elvucitabine shows potent anti-HIV activity in phase II

Oct. 19, 2007

FDA approves use of Lexiva with reduced dose of ritonavir

Oct. 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...